NeoGenomics stockholders approve 4.3 million share increase to equity incentive plan
At its May 22, 2025 annual meeting, NeoGenomics stockholders approved an amendment adding 4,325,000 shares to the 2023 Equity Incentive Plan, along with a one-year minimum vesting period and limits on share recycling. Stockholders also re-elected nine directors, approved executive pay on an advisory basis, and ratified Deloitte & Touche LLP as auditor.
Key points
- Stockholders approved adding 4,325,000 shares to the 2023 Equity Incentive Plan, with 94.90% of votes cast in favor.
- Amendment sets a one-year minimum vesting period for awards and prohibits re-use of shares withheld for taxes and net share counting on option exercises.
- Board will hold advisory votes on named executive compensation every year, after 103,435,850 votes favored annual frequency.
- Deloitte & Touche LLP was ratified as independent registered public accountant with 112,929,861 votes for (99.86% of votes cast).
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.